Prognosis in advanced cancer

https://doi.org/10.1016/S0889-8588(02)00024-2Get rights and content

Section snippets

Prognostic factors in advanced cancer patients: indications from the literature

The first historic works [5], [6] to identify prognostic factors in advanced cancer patients assessed the “Clinical Prediction of Survival” (CPS; ie, the ability of the health professional to estimate the probable life expectancy of patients by using his or her own clinical experience). The CPS proved to be predictive of the Actual Survival (AS) in six out of six studies [5], [7], [8], [9], [10], [11], cited in a recent systematic review, in which this parameter had been evaluated [12]; the

Methodologic issues

Guidelines have been produced to evaluate the methods used and the results obtained from studies on prognostic factors. These guidelines deal with epidemiologic validity, biostatistic consistency, and clinical applicability [115].

Some authors have claimed that studies on prognostic factors in terminal stage patients are lacking in a well-defined “inception cohort” (ie, a homogeneous recruitment at a precise and uniform point in time) [12]. To overcome this problem, several characteristics were

Difficulty in using prognostic factors

Some authors have pointed out that the decision between survival-prolonging treatment and quality of life therapies must also take into account the wishes of the patient. Patients obviously base their preferences, however, on the information that they possess. In one study, patients convinced of having a life expectancy of more than 6 months favored life-extending therapies over comfort care (OR 2.6; 95% CI, 1.8 to 3.7), with respect to those who knew they had at least a 10% chance of not being

Summary

When considered with other parameters, prognostic factors of survival in far advanced cancer patients are necessary to enable the doctor, the patient, and his or her relative to choose the most suitable clinical management and care setting. Original studies and literature reviews, albeit with methodologic difficulties, have identified the most important prognostic factors as being: CPS, KPS, signs and symptoms relating to nutritional status (ie, weight loss, anorexia, dysphagia, xerostomia),

Acknowledgements

The authors thank Ms. Grainne Tierney for editing the manuscript and Ms. Alessandra Pizzigati for her technical assistance.

First page preview

First page preview
Click to open first page preview

References (131)

  • T. Bachelot et al.

    Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials

    Ann Oncol

    (2000)
  • S. Kaasa et al.

    Prognostic factors for patients with inoperable non-small cell lung cancer, limited disease: the importance of patients' subjective experience of disease and psychosocial well-being

    Radiother Oncol

    (1989)
  • R.L. Krech et al.

    Symptoms of pancreatic cancer

    J Pain Symptom Manage

    (1991)
  • V. Ventafridda et al.

    Unendurable symptoms as prognostic indicators of impending death in terminal cancer patients

    Eur J Cancer

    (1990)
  • R.K. Portenoy et al.

    The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress

    Eur J Cancer

    (1994)
  • M. Maltoni et al.

    Biological indices predictive of survival in 519 terminally ill cancer patients

    J Pain Symptom Manage

    (1997)
  • V. Ventafridda et al.

    Leukocyte-lymphocytes ratio: a prognostic indicator of survival in cachectic cancer patients

    Ann Oncol

    (1991)
  • J.M. Muller et al.

    Preoperative parenteral feeding in patients with gastrointestinal carcinoma

    Lancet

    (1982)
  • D.B. Reuben et al.

    Dyspnea in terminally ill cancer patients

    Chest

    (1986)
  • A. Coates

    Prognostic implications of quality of life

    Cancer Treat Rev

    (1993)
  • A. Coates et al.

    Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma

    Eur J Cancer

    (1993)
  • A. Coates et al.

    On the receiving end VI. Which dimensions of quality of life scores carry prognostic information

    Cancer Treat Rev

    (1996)
  • M.K. Schwartz

    Enzymes as prognostic markers and therapeutic indicators in patients with cancer

    Clin Chim Acta

    (1992)
  • T. Morita et al.

    Effects of high dose opioids and sedatives on survival in terminally ill cancer patients

    J Pain Symptom Manage

    (2001)
  • N. Den Daas

    Estimating length of survival in end-stage cancer: a review of the literature

    J Pain Symptom Manage

    (1995)
  • O.S. Selawry

    The individual and the median

  • G.S. Fischer et al.

    Communicating a poor prognosis

  • A. Rich

    How long have I got? Prognostication and palliative care

    Eur J Palliat Care

    (1999)
  • C.M. Parkes

    Accuracy of predictions of survival in later stages of cancer

    Br Med J

    (1972)
  • J. Scotto et al.

    Predicting survival in terminal cancer

    Br Med J

    (1972)
  • M. Maltoni et al.

    Prediction of survival of patients terminally ill with cancer

    Cancer

    (1995)
  • D. Oxenham et al.

    Accuracy of prediction of survival by different professional groups in a hospice

    Palliat Med

    (1998)
  • A. Viganò et al.

    Survival prediction in terminal cancer patients: a systematic review of the medical literature

    Palliat Med

    (2000)
  • A. Viganò et al.

    Clinical survival predictors in patients with advanced cancer

    Arch Intern Med

    (2000)
  • A. Viganò et al.

    The relative accuracy of the clinical estimation of the duration of life for patients with end of life cancer

    Cancer

    (1999)
  • E.B. Lamont et al.

    Some elements of prognosis in terminal cancer

    Oncology

    (1999)
  • L.E. Forster et al.

    Predicting life span for applicants to inpatients hospice

    Arch Intern Med

    (1988)
  • L.H. Heyse-Moore et al.

    Can doctors accurately predict the life expectancy of patients with terminal cancer?

    Palliat Med

    (1987)
  • N.A. Christakis et al.

    Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study

    Br Med J

    (2000)
  • A. Tversky et al.

    Judgement under uncertainty: heuristics and biased

    Science

    (1974)
  • N.D. Weinstein

    Optimistic biases about personal risks

    Science

    (1989)
  • J.M. Addington-Hall et al.

    Can the Spitzer Quality of Life Index help to reduce uncertainty in terminal care?

    Br J Cancer

    (1990)
  • C.L. Loprinzi et al.

    Prospective evaluation of prognostic variables from patient-completed questionnaires

    J Clin Oncol

    (1994)
  • M.F. Muers et al.

    Prognosis in lung cancer: physicians opinions compared with outcome and a predictive model

    Thorax

    (1996)
  • M.A. Rosenthal et al.

    Prediction of life expectancy in hospice patients: identification of novel prognostic factors

    Palliat Med

    (1993)
  • N.A. Christakis

    Death foretold: prophecy and prognosis and medical care

    (1999)
  • R.M. Poses et al.

    Are two (inexperienced) heads better than one (experienced) head? Averaging house officers' prognostic judgments for critically ill patients

    Arch Intern Med

    (1990)
  • W.A. Knaus et al.

    The SUPPORT prognostic model. Objective estimates of survival for seriously ill hospitalized adults

    Ann Intern Med

    (1995)
  • P. Allard et al.

    Factors associated with length of survival among 1081 terminally ill cancer patients

    J Palliat Care

    (1995)
  • L.E. Forster et al.

    The use of physiologic measures and demographic variables to predict longevity among inpatient hospice applicants

    Am J Hospice Care

    (1989)
  • Cited by (52)

    • Development of a nutritional risk screening tool for cancer patients undergoing outpatient treatment

      2022, Clinical Nutrition ESPEN
      Citation Excerpt :

      Another study conducted in 2020 in Germany with 539 patients with lung cancer aimed to associate the nutritional status, which was measured by the Controlling Nutritional Status (CONUT) and the Prognostic Nutritional Index (PNI), with the prognosis of these patients, and observed that individuals with KPS below 80%, the mean value of KPS in our malnourished group, presented a worse nutritional status [26]. The KPS and the nutritional status are important factors for assessing prognosis in cancer patients [27], and the combination of these factors may have important predictive value. In the present study, the KPS was one of the variables that was most associated with malnutrition in the outpatient clinic.

    • Development and validation of a novel nomogram predicting 10-year actual survival after curative hepatectomy for hepatocellular carcinoma

      2021, Surgeon
      Citation Excerpt :

      Serum albumin is known to be a marker to assess nutritional status and reflects the underlying liver function. Some studies have showed that serum albumin is an independent prognostic factor of survival for cancers.35,36 Microvascular invasion reflects poor biological behavior of HCC.

    View all citing articles on Scopus
    View full text